Extra gene coding capacity of SARS-CoV-2 provides a virus engineering platform for in vitro and in vivo applications

Taksoo Kim, Asim Biswas, Sangam Kandel, Makoto Kuroda, Peter J. Halfmann, Yoshihiro Kawaoka

Open source

DOI
10.1073/pnas.2532920123
Published
2026-06-24
Container
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1073/pnas.2532920123,
  title = {Extra gene coding capacity of SARS-CoV-2 provides a virus engineering platform for in vitro and in vivo applications},
  author = {Taksoo Kim and Asim Biswas and Sangam Kandel and Makoto Kuroda and Peter J. Halfmann and Yoshihiro Kawaoka},
  year = {2026},
  journal = {Proceedings of the National Academy of Sciences},
  doi = {10.1073/pnas.2532920123},
  url = {https://doi.org/10.1073/pnas.2532920123}
}

RIS

TY  - JOUR
TI  - Extra gene coding capacity of SARS-CoV-2 provides a virus engineering platform for in vitro and in vivo applications
AU  - Taksoo Kim
AU  - Asim Biswas
AU  - Sangam Kandel
AU  - Makoto Kuroda
AU  - Peter J. Halfmann
AU  - Yoshihiro Kawaoka
PY  - 2026
JO  - Proceedings of the National Academy of Sciences
DO  - 10.1073/pnas.2532920123
UR  - https://doi.org/10.1073/pnas.2532920123
ER  - 

APA

Kim, T., Biswas, A., Kandel, S., Kuroda, M., Halfmann, P. J., & Kawaoka, Y. (2026). Extra gene coding capacity of SARS-CoV-2 provides a virus engineering platform for in vitro and in vivo applications. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2532920123

Source records